DNA framework-based nanomedicine platform: a triple-function strategy for treating periodontitis via antibacterial, anti-inflammatory, and osteogenesis-promoting activities

Abstract

Periodontitis is the most prevalent chronic inflammatory condition affecting oral health and is associated with long treatment duration. It is triggered by microbial plaque, which leads to localized and diffuse inflammation, ultimately causing progressive and irreversible damage to the alveolar bone and connective tissue. Therefore, early and effective treatment strategies should prioritize both antimicrobial and anti-inflammatory interventions. Herein, we report a multifunctional DNA nanodrug delivery platform based on tetrahedral framework nucleic acids (tFNAs), which effectively delivers curcumin and defensin to periodontal tissues. This platform exhibits a triple therapeutic effect by eliminating periodontal pathogenic bacteria, reducing inflammatory infiltration in periodontal tissues, and inhibiting bone resorption and degradation. Experimental results showed that curcumin was uniformly loaded onto the framework nucleic acid via groove binding, while defensin was anchored via chemical conjugation, forming the curcumin–defensin–tFNA (Cur-de-tFNA) complex. Due to its structural advantages, this nanodrug platform demonstrates exceptional cellular uptake efficiency and biosafety, significantly enhancing the bioavailability of curcumin and the antimicrobial activity of defensin. Moreover, as the platform degrades into nucleic acids, it presents one of the cleanest nanodrug delivery platforms currently available. As anticipated, the complex demonstrated potent antimicrobial activity, modulated the TLR4 pathway, improved the local microenvironment, promoted the expression of osteogenic proteins, and alleviated local tissue inflammation in a rat model of periodontitis, effectively reducing alveolar bone resorption. We believe that this study offers meaningful insights for multi-targeted combination therapies for periodontitis and provides new directions for the management of bacterial infection-induced local inflammation and bone resorption-related diseases.

References

[1] Kinane DF, Stathopoulou PG, Papapanou PN. Periodontal diseases. Nature Reviews. Disease Primers, 2017, 3 Article ID: 17038

[2] Nilsson H, Sanmartin Berglund J, Renvert S. Longitudinal evaluation of periodontitis and tooth loss among older adults. Journal of Clinical Periodontology, 2019, 46: 1041-1049

[3] Siow DSF, Goh EXJ, Ong MMA, Preshaw PM. Risk factors for tooth loss and progression of periodontitis in patients undergoing periodontal maintenance therapy. Journal of Clinical Periodontology, 2023, 50: 61-70

[4] Hajishengallis G. Interconnection of periodontal disease and comorbidities: Evidence, mechanisms, and implications. Periodontology 2000, 2022, 89: 9-18

[5] Wang X, et al.. Periodontitis-related myocardial fibrosis by expansion of collagen-producing SiglecF+ neutrophils. European Heart Journal, 2025, 46: 2223-2238

[6] Zhou LJ, et al.. Periodontitis exacerbates atherosclerosis through Fusobacterium nucleatum-promoted hepatic glycolysis and lipogenesis. Cardiovascular Research, 2023, 119: 1706-1717

[7] Genco RJ, Borgnakke WS. Diabetes as a potential risk for periodontitis: association studies. Periodontology 2000, 2020, 83: 40-45

[8] Yay E, et al.. Oral and gut microbial profiling in periodontitis and Parkinson’s disease. Journal of Oral Microbiology, 2024, 16 Article ID: 2331264

[9] Rubinstein T, et al.. Periodontitis and brain magnetic resonance imaging markers of Alzheimer’s disease and cognitive aging. Alzheimer’s & Dementia : the Journal of the Alzheimer’s Association, 2024, 20: 2191-2208

[10] Di Stefano, M. et al. Impact of Oral Microbiome in Periodontal Health and Periodontitis: A Critical Review on Prevention and Treatment. Int. J. Mol. Sci.23, https://doi.org/10.3390/ijms23095142 (2022).

[11] Sczepanik FSC, et al.. Periodontitis is an inflammatory disease of oxidative stress: We should treat it that way. Periodontology 2000, 2020, 84: 45-68

[12] Neurath N, Kesting M. Cytokines in gingivitis and periodontitis: from pathogenesis to therapeutic targets. Frontiers in Immunology, 2024, 15 Article ID: 1435054

[13] Xie X, et al.. IKK/NF-κB and ROS signal axes are involved in Tenacissoside H mediated inhibitory effects on LPS-induced inflammatory osteolysis. Cell Proliferation, 2024, 57 Article ID: e13535

[14] Zhang M, Liu Y, Afzali H, Graves DT. An update on periodontal inflammation and bone loss. Frontiers in Immunology, 2024, 15 Article ID: 1385436

[15] Paternò Holtzman L, et al.. Change in clinical parameters after subgingival instrumentation for the treatment of periodontitis and timing of periodontal re-evaluation: A systematic review and meta-analysis. Journal of Clinical Periodontology, 2025, 52: 137-158

[16] Li S, Tian T, Zhang T, Lin Y, Cai X. A bioswitchable delivery system for microRNA therapeutics based on a tetrahedral DNA nanostructure. Nature Protocols, 2025, 20: 336-362

[17] Yao L, et al.. Development of an Inhalable DNA Tetrahedron MicroRNA Sponge. Advanced Materials (Deerfield Beach, Fla.), 2025, 37 Article ID: e2414336

[18] Shi R, Zhu Y, Chen Y, Lin Y, Shi S. Advances in DNA nanotechnology for chronic wound management: Innovative functional nucleic acid nanostructures for overcoming key challenges. Journal of Controlled Release : Official Journal of the Controlled Release Society, 2024, 375: 155-177

[19] Tang B, Ma W, Lin Y. Emerging applications of anti-angiogenic nanomaterials in oncotherapy. Journal of Controlled Release: Official Journal of the Controlled Release Society, 2023, 364: 61-78

[20] Yao Y, Yang M, Shi S. Nucleic Acid Nanomaterials-based Therapy for Osteoarthritis: Progress and Prospects. Current Drug Metabolism, 2023, 24: 338-352

[21] Cui W, et al.. Effects of tetrahedral DNA nanostructures on the treatment of osteoporosis. Cell Proliferation, 2024, 57 Article ID: e13625

[22] Liu J, Cabral H, Mi P. Nanocarriers address intracellular barriers for efficient drug delivery, overcoming drug resistance, subcellular targeting and controlled release. Advanced Drug Delivery Reviews, 2024, 207 Article ID: 115239

[23] Zhou M, et al.. Framework Nucleic Acid-Based and Neutrophil-Based Nanoplatform Loading Baicalin with Targeted Drug Delivery for Anti-Inflammation Treatment. ACS Nano, 2025, 19: 3455-3469

[24] Zhou M, et al.. A DNA-based nanorobot for targeting, hitchhiking, and regulating neutrophils to enhance sepsis therapy. Biomaterials, 2025, 318 Article ID: 123183

[25] Sun J, Chen X, Lin Y, Cai X. MicroRNA-29c-tetrahedral framework nucleic acids: Towards osteogenic differentiation of mesenchymal stem cells and bone regeneration in critical-sized calvarial defects. Cell Proliferation, 2024, 57 Article ID: e13624

[26] Yang Y, et al.. A DNA tetrahedron-based nanosuit for efficient delivery of amifostine and multi-organ radioprotection. Bioactive Materials, 2024, 39: 191-205

[27] Lyu X, et al.. A Multifunctional Nanocomplex as miRNA/Antibiotic Co-Delivery System Based on Tetrahedral Framework DNA: Application to Infected Wound Healing. Small (Weinheim an der Bergstrasse, Germany), 2024, 20 Article ID: e2406629

[28] Jiang Z, et al.. A Noninvasive Nanoeyedrop Therapy for the Inhibition of Uveal Melanoma: Tetrahedral Framework Nucleic Acid-Based Bioswitchable MicroRNA Delivery System. ACS Nano, 2025, 19: 14756-14769

[29] Zhang, G. et al. Tetrahedral Framework Nucleic Acids as an Efficient Nasal-to-Brain Delivery Carrier via Neural Transport Pathways. n/a, 2419914, https://doi.org/10.1002/adfm.202419914.

[30] Zheng Y, et al.. Transepithelial transport of nanoparticles in oral drug delivery: From the perspective of surface and holistic property modulation. Acta Pharmaceutica Sinica. B, 2024, 14: 3876-3900

[31] Dhariwala MO, Scharschmidt TC. The best offense is a good beta-defensin. Immunity, 2022, 55: 1586-1588

[32] Dong X, et al.. Keratinocyte-derived defensins activate neutrophil-specific receptors Mrgpra2a/b to prevent skin dysbiosis and bacterial infection. Immunity, 2022, 55: 1645-1662.e1647

[33] Ashrafizadeh M, et al.. Toward Regulatory Effects of Curcumin on Transforming Growth Factor-Beta Across Different Diseases: A Review. Frontiers in Pharmacology, 2020, 11 Article ID: 585413

[34] Sadeghi M, et al.. Curcumin and chemokines: mechanism of action and therapeutic potential in inflammatory diseases. Inflammopharmacology, 2023, 31: 1069-1093

[35] Zhang G, et al.. Nano shield: a new tetrahedral framework nucleic acids-based solution to radiation-induced mucositis. Nanoscale, 2023, 15: 7877-7893

[36] Zhang M, et al.. Anti-inflammatory activity of curcumin-loaded tetrahedral framework nucleic acids on acute gouty arthritis. Bioactive Materials, 2022, 8: 368-380

[37] Iniesta M, et al.. Subgingival microbiome in periodontal health, gingivitis and different stages of periodontitis. Journal of Clinical Periodontology, 2023, 50: 905-920

[38] Herrera, D., van Winkelhoff, A. J., Matesanz, P., Lauwens, K. & Teughels, W. Europe’s contribution to the evaluation of the use of systemic antimicrobials in the treatment of periodontitis. Periodontology 2000, https://doi.org/10.1111/prd.12492 (2023).

[39] Kim, H. J. et al. Anti-Inflammatory Effects of the LK5 Herbal Complex on LPS- and IL-4/IL-13-Stimulated HaCaT Cells and a DNCB-Induced Animal Model of Atopic Dermatitis in BALB/c Mice. Pharmaceutics16, https://doi.org/10.3390/pharmaceutics16010040 (2023).

[40] Wang D, et al.. Dual delivery of an NF-κB inhibitor and IL-10 through supramolecular hydrogels polarizes macrophages and promotes cardiac repair after myocardial infarction. Acta Biomaterialia, 2023, 164: 111-123

[41] Chen L, et al.. A biodegradable magnesium alloy promotes subperiosteal osteogenesis via interleukin-10-dependent macrophage immunomodulation. Biomaterials, 2025, 318 Article ID: 122992

[42] Zhou G, et al.. Synthetically Engineered Bacterial Extracellular Vesicles and IL-4-Encapsulated Hydrogels Sequentially Promote Osteoporotic Fracture Repair. ACS nano, 2025, 19: 16064-16083

[43] Kwon, O. Y. & Lee, S. H. Ishige okamurae Attenuates Neuroinflammation and Cognitive Deficits in Mice Intracerebroventricularly Injected with LPS via Regulating TLR-4/MyD88-Dependent Pathways. Antioxidants (Basel, Switzerland)12, https://doi.org/10.3390/antiox12010078 (2022).

[44] Chen J, et al.. The application of human periodontal ligament stem cells and biomimetic silk scaffold for in situ tendon regeneration. Stem Cell Research & therapy, 2021, 12: 596

[45] Zhu L, et al.. AFF4 regulates osteogenic potential of human periodontal ligament stem cells via mTOR-ULK1-autophagy axis. Cell Proliferation, 2024, 57 Article ID: e13546

[46] Wei J, et al.. Glucose Uptake and Runx2 Synergize to Orchestrate Osteoblast Differentiation and Bone Formation. Cell, 2015, 161: 1576-1591

[47] Mustafa H, et al.. Induction of periodontal disease via retentive ligature, lipopolysaccharide injection, and their combination in a rat model. Polish Journal of Veterinary Sciences, 2021, 24: 365-373

[48] Bosshardt DD. The periodontal pocket: pathogenesis, histopathology and consequences. Periodontology 2000, 2018, 76: 43-50

[49] Yuan Z, et al.. Sinensetin protects against periodontitis through binding to Bach1 enhancing its ubiquitination degradation and improving oxidative stress. International Journal of Oral Science, 2024, 16: 38

[50] Kapila YL. Oral health’s inextricable connection to systemic health: Special populations bring to bear multimodal relationships and factors connecting periodontal disease to systemic diseases and conditions. Periodontology 2000, 2021, 87: 11-16

[51] Villoria GEM, Fischer RG, Tinoco EMB, Meyle J, Loos BG. Periodontal disease: A systemic condition. Periodontology 2000, 2024, 96: 7-19

[52] Zhou M, et al.. C-reactive protein perturbs alveolar bone homeostasis: An experimental study of periodontitis and diabetes in the rat. Journal of Clinical Periodontology, 2022, 49: 1052-1066

[53] White P, et al.. Peripheral blood neutrophil extracellular trap production and degradation in chronic periodontitis. Journal of Clinical Periodontology, 2016, 43: 1041-1049

[54] Liu Z, et al.. Multidimensional Applications and Challenges of Metal-Organic Frameworks (MOFs) in Biomedicine: From Drug Safety Evaluation to Drug Delivery. Journal of Biomedical Materials Research. Part A, 2025, 113 Article ID: e37952

[55] Wiśniewska, P., Haponiuk, J., Saeb, M. R., Rabiee, N. & Bencherif, S. A. Mitigating Metal-Organic Framework (MOF) Toxicity for Biomedical Applications. Chem. Eng. J. (Lausanne, Switzerland : 1996)471, https://doi.org/10.1016/j.cej.2023.144400 (2023).

[56] Vodyashkin, A. A., Sergorodceva, A. V., Kezimana, P. & Stanishevskiy, Y. M. Metal-Organic Framework (MOF)-A Universal Material for Biomedicine. Int. J. Mol. Sci.24, https://doi.org/10.3390/ijms24097819 (2023).

[57] Chaurasiya A, Gorajiya A, Panchal K, Katke S, Singh AK. A review on multivesicular liposomes for pharmaceutical applications: preparation, characterization, and translational challenges. Drug Delivery and Translational Research, 2022, 12: 1569-1587

[58] Ferreira Soares DC, Domingues SC, Viana DB, Tebaldi ML. Polymer-hybrid nanoparticles: Current advances in biomedical applications. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 2020, 131 Article ID: 110695

[59] Chen X, et al.. Sulfated Chitosan-Modified CuS Nanocluster: A Versatile Nanoformulation for Simultaneous Antibacterial and Bone Regenerative Therapy in Periodontitis. ACS Nano, 2024, 18: 14312-14326

[60] Tang Y, et al.. Erythrocyte-Mimicking Nanovesicle Targeting Porphyromonas gingivalis for Periodontitis. ACS Nano, 2024, 18: 21077-21090

[61] Guo Q, et al.. Conditioned media of deer antler stem cells accelerate regeneration of alveolar bone defects in rats. Cell Proliferation, 2023, 56 Article ID: e13454

[62] Justo MP, et al.. Curcumin reduces inflammation in rat apical periodontitis. International Endodontic Journal, 2022, 55: 1241-1251

Funding

National Natural Science Foundation of China (National Science Foundation of China)(82322015, 82171006)

Sichuan Province Youth Science and Technology Innovation Team(2022JDTD0021)

RIGHTS & PERMISSIONS

The Author(s)